Want to take quizzes and track your credits?
A 56-year-old woman presented to her cardiologist with stable atypical chest pain. A 20% pretest probability of coronary artery disease (CAD) was estimated, considering sex, age, and type of chest pain.1 Functional tests performed 3 months earlier were inconclusive: a stress electrocardiogram (ECG) showed ST-segment depressions at 100 W of −0.2 mV in lead I and −0.15 mV in V5, while stress magnetic resonance (MR) perfusion imaging had negative results. The patient had cardiovascular risk factors including arterial hypertension and a family history of CAD. With antihypertensive therapy, her blood pressure was 119/79 mm Hg. Blood lipids were as follows: total cholesterol, 167 mg/dL (abnormal >200 mg/dL); low-density lipoprotein cholesterol, 80 mg/dL (abnormal >100 mg/dL); high-density lipoprotein cholesterol, 55 mg/dL (abnormal <60 mg/dL); and triglycerides, 80 mg/dL (abnormal >150 mg/dL). To evaluate for CAD, she underwent coronary computed tomography (CT) angiography (Figure).
Please finish quiz first before checking answer.
Read the answer below and download your certificate.
Read the discussion below and retake the quiz.
C. No stenosis or plaque. Because of high negative predictive value, no further testing is necessary.
Invasive coronary angiography (ICA) is the reference procedure for detecting obstructive CAD; however, approximately two-thirds of ICAs performed fail to reveal any CAD, and these patients need no interventional therapy.2 Coronary CT angiography is a noninvasive diagnostic test with high diagnostic accuracy (97% sensitivity, 87% specificity, 95% negative predictive value, and area under the curve of 0.93 [95% CI, 0.91-0.95] even if nonevaluable scans are included),3 and if performed as an initial test, it can improve the diagnostic yield of ICA.2,4 New European Society of Cardiology (ESC) guidelines recommend coronary CT angiography for patients with stable chest pain, especially when they have low to intermediate pretest disease probability.1 With its high sensitivity and resulting high negative predictive value, CT angiography is especially suited as a test to rule out ICA. This is important as ICA is still associated with a low risk of relevant complications such as coronary occlusion, coronary infarction, cerebral infarction, and artery dissection.5 Both ICA and coronary CT angiography require the administration of a contrast agent, and both should be avoided in patients with kidney failure (glomerular filtration rate <30 mL/min). Coronary CT angiography can be performed rapidly (about 5 minutes) and does not require hospitalization. The scan is performed with ECG triggering, which means that in patients with a low and stable heart rate, acquisition is confined to predefined intervals of the cardiac R-R cycle (prospective scan) instead of a retrospective scan of the entire R-R interval. This improves general image quality by reducing motion artifacts while at the same time, lowering radiation exposure. Another option to reduce radiation exposure is dose modulation, which can be used in conjunction with retrospective gating. Patients with contraindications to nitroglycerin (eg, arterial hypotension), β-blockers (eg, bradycardia, asthma, acute heart failure, or bronchospasm), or contrast agent (eg, documented previous severe reaction, kidney failure) should undergo alternative diagnostic testing. To optimize diagnostic accuracy and reduce radiation exposure, careful patient preparation is necessary.6
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Marc Dewey, MD, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany (email@example.com).
Published Online: September 23, 2020. doi:10.1001/jama.2020.10831
Conflict of Interest Disclosures: Dr Dewey reports receipt of grant support from the European Commission, the German Research Foundation (DFG), Berlin University Alliance, and the Berlin Institute of Health; lecture fees from Canon, Guerbet, Cardiac MR Academy of Berlin, and Bayer; personal fees as editor of Cardiac CT; other for courses on CT imaging; voluntary service as research chair for the European Society of Radiology (only travel expenses); institutional master research agreements with Siemens, General Electric, Philips, and Canon (managed by the legal department of Charité–Universitätsmedizin Berlin); and a joint patent on dynamic perfusion analysis using fractal analysis (all outside the submitted work). Dr Feger reports no disclosures.
Disclaimer: The opinions in this article are the authors’ and do not represent the view of ESR.
Additional Contributions: We thank the patient for providing permission to share her information, the radiographic staff, and referring physicians. In addition, we thank Bettina Herwig for copy editing.
You currently have no searches saved.